Betamethasone Clotrimazole (Lotriderm) shortage status
No current shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Betamethasone Clotrimazole has no current shortage reported in Canada. It has been in shortage before; the history is below.
A topical combination of a steroid and an antifungal used to treat inflamed fungal skin infections.
Products affected
0 / 2
Reports on file
21
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE
0.05%
1% · CREAM · TARO PHARMACEUTICALS INC
DIN 02496410 · ended Feb 4, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE
0.05%
1% · CREAM · TARO PHARMACEUTICALS INC
DIN 02496410 · ended Aug 20, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE
0.05%
1% · CREAM · TARO PHARMACEUTICALS INC
DIN 02496410 · ended Jul 25, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE
1%
0.05% · CREAM · TARO PHARMACEUTICALS INC
DIN 02496410 · ended Mar 4, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE
1%
0.05% · CREAM · TARO PHARMACEUTICALS INC
DIN 02496410 · ended Feb 27, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE
1%
0.05% · CREAM · TARO PHARMACEUTICALS INC
DIN 02496410 · ended May 24, 2024 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE
1%
0.05% · CREAM · TARO PHARMACEUTICALS INC
DIN 02496410 · ended Nov 29, 2022 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE
1%
0.05% · CREAM · TARO PHARMACEUTICALS INC
DIN 02496410 · ended Oct 17, 2021 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE
1%
0.05% · CREAM · TARO PHARMACEUTICALS INC
DIN 02496410 · ended Jul 29, 2021 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE
0.05%
1% · CREAM · TARO PHARMACEUTICALS INC
DIN 02496410 · ended Feb 24, 2021 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE
0.05%
1% · CREAM · TARO PHARMACEUTICALS INC
DIN 02496410 · ended Feb 12, 2021 · Disruption of the manufacture of the drug.
Resolved
LOTRIDERM CREAM
0.05%
1% · CREAM · MERCK CANADA INC
DIN 00611174 · ended Apr 2, 2020 · Demand increase for the drug.
Showing 12 of 21 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Betamethasone Clotrimazole. Health Canada has 21 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Betamethasone Clotrimazole is classified under “ANTIFUNGALS FOR TOPICAL USE” (ATC D01AC).
Recent changes
No changes recorded yet.
Common questions
What is Betamethasone Clotrimazole used for?
A topical combination of a steroid and an antifungal used to treat inflamed fungal skin infections.
When will Betamethasone Clotrimazole be back in stock in Canada?
Betamethasone Clotrimazole has no active shortage; supply is normal per Health Canada reports.
Why is Betamethasone Clotrimazole in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.